Objective: To assess the efficacy, safety and tolerability of moxifloxacin, an 8-methoxy fluoroquinolone, in patients with respiratory tract infections (RTIs) treated in general practice in Germany.

In this substantial population of patients with RTI, most experienced a rapid improvement of symptoms commonly associated with RTIs after moxifloxacin treatment. Over 89% of patients were judged ...

The HCL journey has been relentless, gratifying and marked with a series of achievements. Our unified efforts have catapulted the company from a garage start-up to a conglomerate whose businesses span ...

night maharashtra chart The Chinese team developed a new coronavirus vaccine that has demonstrated its preventive potential in non-human primate models Hisun Pharmaceuticals' Moxifloxacin ...

Bonus May 05, 1995 Jun 01, 1995 Feb 16, 1995 Bonus Ratio: 1 share(s) for every 2 shares held Rights Aug 07, 1992 Sep 01, 1992 Sep 30, 1992 Rights ratio: 1 share for every 1 held at a price of Rs 60.0 ...

Shares of HCL Technologies tanked over 9% on Tuesday after the company reported its results for the third quarter of FY25. While, the company’s earnings were in-line with market expectations, the ...

winter suits for ladies Hunan Provincial Medical Insurance Bureau issued a notice to crack down on insurance fraud nationwide Development terminated! Millendo's new drug for rare disease fails Phase ...

In a knee-jerk reaction to its quarter earnings for the December 2024 quarter, Shares of HCL Technologies Ltd cracked more than 9 per cent during the trading session on Tuesday on the back of ...

Infosys results would be out post market hours, around 3:45 pm. Among major IT firms, Tata Consultancy Services Ltd and HCL Technologies Ltd have already reported quarterly results. Wipro will ...

HCL Technologies (HCL Tech) on Monday, January 13, 2025, declared an interim dividend of ₹12 per share and a special dividend of ₹6 per share. The announcement came along with the IT major declaring ...